Pfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The US FDA has granted full approval to Moderna’s COVID-19 vaccine Spikevax for use in children aged six months to 11 years ...

“Razor blade sore throat” has been reported as a symptom of Covid Nimbus by doctors and medical professionals internationally ...

Intense throat pain is a key symptom of COVID-19 variant NB.1.8.1, referred to as "razor blade throat." Here's what to know.

Moderna's Spikevax was previously available for paediatric populations under emergency use authorisation. Moderna expects to make its updated vaccine available for eligible  US population for the 2025 ...

Here's what is known about the new Covid XFG, or 'Stratus', variant from UK cases and symptoms to what the World Health Organisation has said ...

Karnataka CM's claim on vaccine-linked heart deaths faces expert rebuttal. Health authorities stress no scientific evidence ...

Starting today, the inquest will hear from everyday people about what the government's decisions over vaccines and lockdowns ...